Effect of ciprofloxacin on the activation of the transcription factors nuclear factor κB, activator protein-1 and nuclear factorinterleukin-6, and interleukin-6 and interleukin-8 mRNA expression in a human endothelial cell line 
INTRODUCTION
Fluorinated-4-quinolones, including ciprofloxacin, are nalidixic acid analogue antibiotics which exert their bactericidal effect by inhibiting DNA gyrase activity. In addition to their antibacterial properties, they have been shown to modify immune and inflammatory responses in some cells. Both inhibitory and enhancing effects of ciprofloxacin on the production of some cytokines have been described, depending on the concentration of the antibiotic and the cell type [1] [2] [3] [4] [5] [6] [7] . We have shown previously that ciprofloxacin decreases interleukin (IL)-6 accumulation from a human endothelial cell line, whilst IL-8 production was decreased at lower ciprofloxacin concentrations and increased at higher concentrations [8] .
IL-6 is a multi-functional protein with roles in host defence, acute-phase reactions, inflammation and immunity. It is up-regulated by mitogenic and antigenic stimuli, lipopolysaccharide, calcium ionophore, IL-1β, IL-2, interferon γ (IFNγ), tumour necrosis factor α (TNFα) and viruses. IL-8 is a potent neutrophil chemotactic and activating factor produced by many different cells in response to IL-1β, TNFα, lipopolysaccharide, histamine and viruses. In man both IL-6 and IL-8 have been shown to be regulated by a number of transcription factors, apparently depending upon the cell type and stimulus, and including nuclear factor κB (NFκB), activator protein-1 (AP-1) and nuclear factor IL-6 (NF-IL-6), which shares sequence similarity with CCAAT\ enhancer binding protein-β. It is not known whether the effects of ciprofloxacin on IL-6 and IL-8 occur through effects on transcription and mRNA expression. We therefore investigated the effect of ciprofloxacin in a human endothelial cell line, on IL-6 and IL-8 mRNA, and on the transcription factors NFκB, AP-1 and NF-IL-6, known to be involved in the regulation of these cytokines.
METHODS

Cell culture
The human endothelial cell line EAhy926 was used for all experiments. The cell line, which is a hybrid from a fusion of primary human umbilical cells and the cell line A549, has been well characterized in terms of factor VIII expression, von Willebrand factor gene expression, and other endothelium specific genes [9] [10] [11] . Confluent cells were cultured in Dulbecco's modified Eagle's medium Glutamax (Gibco BRL, Paisley, Scotland, U.K.) supplemented with 10 % (v\v) foetal calf serum and 100 units\ml penicillin\streptomycin, as described previously [8] , in the presence of 100 units\ml TNFα, 25 units\ml IL-1β (human recombinant, R&D Systems, Abingdon, Oxon, U.K.) with and without ciprofloxacin. Ciprofloxacin hydrochloride (Bayer, Wuppertal, Germany) was initially dissolved in 100 µl of 40 % methanol\10 % acetic acid (1 : 1, v\v), filter sterilized and then diluted in medium to give a final concentration of 1, 10, 50 or 100 µg\ml ciprofloxacin. Control cells (no ciprofloxacin) contained only medium with an equivalent amount of methanol\acetic acid. All cells were then incubated for 2 h (transcription factors) or 6 h (mRNA) at 37 mC in a humidified atmosphere of 5 % CO # \95 % air. These incubation times were determined in initial optimization experiments to coincide with maximal transcriptional activation and mRNA levels (results not shown) and concur with previous studies.
Reverse transcriptase (RT)-PCR
Total RNA was extracted as described previously [12] . The purity of RNA was verified by an absorption ratio of 1.7-2.0 at 260 nm\280 nm and quantified at 260 nm. cDNA was prepared using the Superscript4 kit (Gibco BRL) and used as a template for RT-PCR using specific primer pairs for IL-6, IL-8 and β2-microglobulin. PCR cycles were as follows : denaturing (94 mC, 30 s), annealing (60 mC, 30 s) and extension (70 mC, 1 min). The number of cycles was optimized in the linear phase for each cytokine [13] . PCR products were electrophoresed on an ethidium bromide stained 2 % (w\v) agarose\Tris acetate\EDTA gel at 100 V in the presence of molecularmass marker VI (Boehringer Mannheim, Lewes, Sussex). Gels were captured as digital images and comparative determinations made using Molecular Analyst4 (BioRad Laboratories, Hemel Hempstead, Herts., U.K.). Results were calculated in relation to β2-microglobulin mRNA and expressed as a percentage of expression in the absence of ciprofloxacin to minimize inter-assay variation.
Electrophoretic mobility shift assay
In separate experiments, following incubation, cells were mechanically detached and nuclear extracts were prepared by hypotonic lysis followed by high-salt extraction [14] . Briefly, cells were resuspended in buffer containing 10 mM Hepes, pH 7.9, 10 mM KCl and protease inhibitor cocktail (Boehringer Mannheim) and incubated on ice for 15 min. IGEPAL CA 630 (Sigma Chemical Co. Ltd., Poole, Dorset, U.K.) was added to a final concentration of 1.25 % (v\v), prior to vortex mixing for 15 s. Cells were then pelleted at 10 000 g for 30 s, resuspended in buffer at pH 7.9, containing 20 mM Hepes, 10 mM NaCl, 5 % (v\v) glycerol and protease inhibitor cocktail, and shaken for 1 h at 4 mC. Following centrifugation, supernatants were stored at k80 mC until analysis. The protein content of the nuclear extract was determined spectrophotometrically using Bradford reagent (Sigma).
Probes (Promega, Chilworth, Southampton, Hants., U.K.) to the consensus sequences for NFκB [15] and AP-1 [16] and NF-IL-6 specific oligonucleotides [17] were radiolabelled with [γ-$#P]dATP. Unincorporated [γ-$#P]dATP was removed from all probes by centrifugation through a Nick Spin Column (Pharmacia, St. Albans, Herts., U.K.).
Nuclear extracts (2-5 µg) were incubated in 25 mM Tris\HCl buffer, pH 7.5, containing 50 mM KCl, 1 mM dithiothreitol, 5 % glycerol, 0.2 % IGEPAL, 2 µg of poly(dI-dC) and 1 µl of labelled probe (200 c.p.m.) at room temperature for 20 min. Specificity of the probes was confirmed by complete competition by unlabelled oligonucleotide and no competition from non-specific Oct-1 oligonucleotide in excess.
Nuclear proteins were resolved by electrophoresis on a non-denaturing 6 % (w\v) polyacrylamide gel for approx. 2 h at 250 V. Gels were dried and exposed to X-ray film at k80 mC for 8-16 h. Raw data were captured as digital images and quantified using Molecular Analyst4 software (Bio-Rad).
Data are presented as medians (range) and represent between four and six separate experiments. Statistical analysis was performed using Kruskal-Wallis analysis of variance or Mann-Whitney U test as appropriate. A P value of less than 0.05 was regarded as statistically significant.
RESULTS mRNA expression
Specific mRNA following exposure to ciprofloxacin was quantified as a percentage of the expression in the absence of ciprofloxacin to eliminate variation between runs. Basal levels of IL-6 mRNA and IL-8 mRNA increased significantly on stimulation with TNF\IL-1 (Figures 1 Figure 1 Effect of ciprofloxacin on IL-6 mRNA Upper panel : a representative RT-PCR electrophoresis gel of IL-6 mRNA and β2-microglobulin mRNA. EAhy926 cells were treated with 100 units/ml TNFα and 25 units/ml IL-1β and 0-100 µg/ml ciprofloxacin. Ethidium bromide stained bands were visualized under UV light. Lower panel : IL-6 mRNA levels as box and whisker plots with median, 25th and 75th percentile and range, expressed as a percentage of the level in the absence of ciprofloxacin, relative to β2-microglobulin mRNA. P value refers to Kruskal-Wallis analysis of variance ; *P l 0.03, Mann-Whitney U test versus in the absence of ciprofloxacin. Upper panel : a representative RT-PCR electrophoresis gel of IL-8 mRNA and β2-microglobulin mRNA. EAhy926 cells were treated with 100 units/ml TNFα and 25 units/ml IL-1β and 0-100 µg/ml ciprofloxacin. Ethidium bromide stained bands were visualized under UV light. Lower panel : IL-8 mRNA levels as box and whisker plots with median, 25th and 75th percentile and range, expressed as a percentage of the level in the absence of ciprofloxacin, relative to β2-microglobulin mRNA. P value refers to Kruskal-Wallis analysis of variance ; *P l 0.03, Mann-Whitney U test versus in the absence of ciprofloxacin ; **P l 0.02, Mann-Whitney U test versus in the absence of ciprofloxacin. and 2). Ciprofloxacin decreased IL-6 mRNA expression (Kruskal-Wallis, P l 0.04) and post hoc testing showed that IL-6 mRNA expression was significantly lower at a concentration of ciprofloxacin of 100 µg\ml (P l 0.03, Mann-Whitney U test, Figure 1) . Ciprofloxacin also had a significant effect on IL-8 mRNA (Kruskal-Wallis, P l 0.032) and on post-hoc testing, mRNA was significantly increased in the presence of 50 or 100 µg\ml ciprofloxacin (Mann Whitney U test, P l 0.03 and P l 0.02 respectively, Figure 2 ).
Transcription
NFκB activation was not detected in unstimulated cells (Figure 3 ). When cells were treated with TNFα\IL-1β, NFκB activation increased, but ciprofloxacin did not affect the level of activation (Figure 3 ). AP-1 binding was present constitutively at a high level, and did not increase further when cells were exposed to TNFα\IL-1β. In addition, ciprofloxacin had no effect on AP-1 (Figure 3) . NF-IL-6 activation was also present at a basal level in unstimulated cells, but when cells were treated with TNFα and IL-1β, NF-IL-6 activation increased (Figure 3 , Kruskal-Wallis, P l 0.04). When cells were exposed to Upper panel : representative electrophoretic mobility shift assays of nuclear extracts from EAhy926 cells using oligonucleotide probes specific for NFκB, AP-1 and NF-IL-6. EAhy926 cells were treated with 100 units/ml TNFα and 25 units/ml IL-1β and 0-100 µg/ml ciprofloxacin. Lower panel : box and whisker plots with median, 25th and 75th percentile and range showing arbitrary counts from densitometry scanning of autoradiographs, expressed as a percentage of the counts in the absence of ciprofloxacin. P value refers to Kruskal-Wallis analysis of variance ; *P l 0.05, Mann-Whitney U test versus in the absence of ciprofloxacin.
ciprofloxacin NF-IL-6 binding was decreased at the highest concentration studied (Figure 3 , P l 0.04).
DISCUSSION
We have shown that ciprofloxacin has effects on the regulation of TNFα\IL-1β-mediated IL-6 and IL-8 production in a human endothelial cell line. We found decreased IL-6 mRNA expression when cells were exposed to ciprofloxacin with decreased activation of the transcription factor NF-IL-6, but not AP-1 and NFκB. However, the increased IL-8 mRNA expression seen at higher ciprofloxacin concentrations was not associated with changes in any of the three transcription factors studied.
IL-6 and IL-8 are regulated via several transcription factors, apparently depending on the cell type and experimental conditions. In human bone marrow stromal cells IL-6 release is regulated via NFκB alone [18] , but simultaneous activation of both NF-IL-6 and NF-κB is required for IL-1β-stimulated IL-6 production by mesangial cells [19] . In human T-cell lines, phorbol ester mediates IL-6 release using NFκB [20] but IL-8 requires activation of NF-IL-6 in addition to subunit-specific NFκB regulation [21, 22] . NFκB has also been implicated in TNFα-mediated IL-8 production by a human melanoma cell line [23] . In a monocyte cell line, IL-8 production in response to cytomegalovirus is mediated through both AP-1 and NFκB [24] . In the present study we confirmed NFκB activation in response to TNFα\IL-1β in the EAhy926 human endothelial cell line [25] and also showed that these cells express NF-IL-6 and AP-1.
The effect of ciprofloxacin on IL-6 and IL-8 release could be mediated though several different transcription factors or via effects on mRNA. Although NFκB has been shown to be involved in the regulation of both IL-6 and IL-8 in some other cell types, we found no association with NFκB expression and the effects of ciprofloxacin on IL-6 or IL-8 mRNA. AP-1 has not been described previously in the EAhy926 cell line. Reisbeck et al. [26] showed that 80 µg\ml ciprofloxacin increases activation of AP-1 in phytohaemagglutinin-stimulated lymphocytes. However, we found that AP-1 was constitutively expressed in endothelial cells and was not up-regulated in response to activation. No effect of ciprofloxacin was observed, suggesting either cell-typerelated differences or stimulus dependence. We found that NF-IL-6 was also constitutively expressed by the EAhy926 cell line, but unlike AP-1, was up-regulated by TNFα\IL-1β exposure. Decreased IL-6 production by TNFα\IL-1β-stimulated EAhy926 cells in response to ciprofloxacin [8] was reflected by decreased IL-6 mRNA expression, and decreased NF-IL-6 activation. Similarly, other studies of lipopolysaccharide-stimulated human monocytes showed decreased IL-6 production in the presence of 25 µg\ml ciprofloxacin [1] , whereas at less than 10 µg\ml, no effect was seen [2] . Clinically achievable serum concentrations of ciprofloxacin are up to 10 µg\ml, and levels in tissues may be up to four times higher, although levels within endothelial cells in vivo are unknown [27, 28] .
Increased IL-8 mRNA expression at the highest ciprofloxacin concentration found in the present study reflected findings in our previous study that showed increased IL-8 release at 100 µg\ml [8] . Increased mRNA for IL-1α, IL-2, IFNγ, IL-3, IL-4 and TNFα, and increased IL-2 promoter activation in human leucocytes in response to high concentrations of ciprofloxacin have also been shown [29, 30] . Increased IL-8 mRNA in the present study was not associated with NF-IL-6 activation suggesting that IL-8 mRNA is not regulated by NF-IL-6, in contrast to IL-6 mRNA. Studies using the immortalized lymphoma cell line Jurkat, and the murine equivalent EL-4, have shown that at ciprofloxacin concentrations above 25 µg\ml, AP-1 activation is augmented and results in increased mRNA expression for IL-2, IL-4 and IFNγ [30, 31] . We observed no increase in either AP-1 or NFκB activation in the present study. Increased IL-8 release mediated by nitric oxide inhibitors in the EAhy926 cell line was also not regulated through NFκB [25] . DNA-damaging agents and genotoxic stress may increase the stability of gene transcripts and increase the half-lives of cytokine mRNA and subsequent protein release [32] , and may offer an explanation for the increased IL-8 mRNA in the absence of transcriptional regulation seen in our study. Several potential mechanisms could therefore be involved in the effects of ciprofloxacin on cytokines.
In summary we found that ciprofloxacin decreased TNFα\IL-1β-mediated IL-6 mRNA which was reflected by changes in NF-IL-6 activation, but not AP-1 or NFκB, in the human endothelial cell line, EAhy926. Increased IL-8 mRNA in response to ciprofloxacin was not associated with changes in AP-1, NFκB or NF-IL-6. We have shown a modulatory effect on the host response by the antibiotic ciprofloxacin in human endothelial cells. The use of ciprofloxacin may result in alterations in local concentrations of key cytokines and may be a future consideration in antibiotic drug design.
